4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-055075
CEO & President acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cox John · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-12 | Grant or award : show line 1 in the form | +180,000 | 376,877 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-12 | Grant or award : show line 2 in the form Stock option (right to buy) | +285,000 | 285,000 | D |
Loading xslF345X05/ownership.xml…